Näytä suppeat kuvailutiedot

dc.contributor.authorMavropalias, Georgios
dc.contributor.authorSim, Marc
dc.contributor.authorTaaffe, Dennis, R.
dc.contributor.authorGalvão, Daniel A.
dc.contributor.authorSpry, Nigel
dc.contributor.authorKraemer, William, J.
dc.contributor.authorHäkkinen, Keijo
dc.contributor.authorNewton, Robert, U.
dc.date.accessioned2022-01-31T09:35:11Z
dc.date.available2022-01-31T09:35:11Z
dc.date.issued2022
dc.identifier.citationMavropalias, G., Sim, M., Taaffe, D., Galvão, D. A., Spry, N., Kraemer, W., Häkkinen, K., & Newton, R. (2022). Exercise Medicine for Cancer Cachexia : Targeted Exercise to Counteract Mechanisms and Treatment Side Effects. <i>Journal of Cancer Research and Clinical Oncology</i>, <i>148</i>(6), 1389-1406. <a href="https://doi.org/10.1007/s00432-022-03927-0" target="_blank">https://doi.org/10.1007/s00432-022-03927-0</a>
dc.identifier.otherCONVID_104042869
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/79567
dc.description.abstractPurpose -- Cancer-induced muscle wasting (i.e., cancer cachexia, CC) is a common and devastating syndrome that results in the death of more than 1 in 5 patients. Although primarily a result of elevated inflammation, there are multiple mechanisms that complement and amplify one another. Research on the use of exercise to manage CC is still limited, while exercise for CC management has been recently discouraged. Moreover, there is a lack of understanding that exercise is not a single medicine, but mode, type, dosage, and timing (exercise prescription) have distinct health outcomes. The purpose of this review was to examine the effects of these modes and subtypes to identify the most optimal form and dosage of exercise therapy specific to each underlying mechanism of CC. Methods -- The relevant literatures from MEDLINE and Scopus databases were examined. Results -- Exercise can counteract the most prominent mechanisms and signs of CC including muscle wasting, increased protein turnover, systemic inflammation, reduced appetite and anorexia, increased energy expenditure and fat wasting, insulin resistance, metabolic dysregulation, gut dysbiosis, hypogonadism, impaired oxidative capacity, mitochondrial dysfunction, and cancer treatments side-effects. There are different modes of exercise, and each mode has different sub-types that induce vastly diverse changes when performed over multiple sessions. Choosing suboptimal exercise modes, types, or dosages can be counterproductive and could further contribute to the mechanisms of CC without impacting muscle growth. Conclusion -- Available evidence shows that patients with CC can safely undertake higher-intensity resistance exercise programs, and benefit from increases in body mass and muscle mass.en
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherSpringer Science and Business Media LLC
dc.relation.ispartofseriesJournal of Cancer Research and Clinical Oncology
dc.relation.urihttp://dx.doi.org/10.1007/s00432-022-03927-0
dc.rightsCC BY 4.0
dc.subject.otherlihaskato
dc.subject.otherkakeksia
dc.subject.othercancer cachexia
dc.subject.otherinflammation
dc.subject.othertumor
dc.subject.otherexercise
dc.subject.othermuscle wasting
dc.subject.othermuscle atrophy
dc.titleExercise Medicine for Cancer Cachexia : Targeted Exercise to Counteract Mechanisms and Treatment Side Effects
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-202201311334
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.contributor.oppiaineValmennus- ja testausoppifi
dc.contributor.oppiaineScience of Sport Coaching and Fitness Testingen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_dcae04bc
dc.description.reviewstatuspeerReviewed
dc.format.pagerange1389-1406
dc.relation.issn0171-5216
dc.relation.numberinseries6
dc.relation.volume148
dc.type.versionpublishedVersion
dc.rights.copyright© The Author(s) 2022
dc.rights.accesslevelopenAccessfi
dc.subject.ysolihaskunto
dc.subject.ysolihasmassa
dc.subject.ysovoimaharjoittelu
dc.subject.ysosyöpätaudit
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p7382
jyx.subject.urihttp://www.yso.fi/onto/yso/p29135
jyx.subject.urihttp://www.yso.fi/onto/yso/p16233
jyx.subject.urihttp://www.yso.fi/onto/yso/p678
dc.rights.urlhttps://creativecommons.org/licenses/by/4.0/
dc.relation.doi10.1007/s00432-022-03927-0
jyx.fundinginformationOpen Access funding enabled and organized by CAUL and its Member Institutions. No funding was received for this work. The salary of MS is supported by a Royal Perth Hospital Career Advancement Fellowship.
dc.type.okmA2


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot

CC BY 4.0
Ellei muuten mainita, aineiston lisenssi on CC BY 4.0